http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006026083-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70ac3279962803d9462f36d513d37256
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24
filingDate 2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e79f248629cf93d587c9ca1f1234b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f0ee3d7c1a5cc2a3deba71d83c3b5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2637c1553620a07feb10688b9072e8c
publicationDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006026083-A3
titleOfInvention Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
abstract Aqueous, anti-inflammatory steroid compositions in solution form suitable for nasal administration and having a reduced stinging sensation are provided as well as a method for treating inflammation of the nasal mucosa by intranasal administration of anti-inflammatory steroid compositions. These solution compositions may result in enhanced nasal bio-availability. The anti-inflammatory steroid composition suitable for intranasal administration includes an anti-inflammatory steroid in an amount of from about 0.0001 % to about 2.0 (w/v); a cyclodextrin in an amount of from about 0.1 % to about 20 % (w/v); an alcohol co-solvent in an amount of from about .2 % to about 35% (w/v); a crystallization inhibitor where required, an effective amount of an antimicrobial preservative; an effective amount of an antioxidant; an effective amount of a chelating agent; water; and a pH adjusting agent sufficient to adjust the pH of the composition to from about 4 to about 7.
priorityDate 2004-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6294186-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 22.